Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study

Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study

Abstract Background The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in patients with weight regain after bariatric surgery remains unclear. The objective of this study was to determine the efficacy and safety of 12 months of GLP1-RA treatment in a real-world patient population with...

Full description

Saved in:
Bibliographic Details
Main Authors: Anders Boisen Jensen, Ursina Machado, Frida Renström, Stefan Aczél, Patrick Folie, Magdalena Biraima-Steinemann, Stefan Bilz
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Endocrine Disorders
Subjects:
Bariatric surgery
GLP-1 receptor agonist
Liraglutide
Semaglutide
Weight regain
Online Access:https://doi.org/10.1186/s12902-025-01913-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items